Hayley Miller, MD
Internal Medicine · Missoula, MTNPI 1366672578
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,296 of the $66,513 with a category attached, or 83.1%. Novo Nordisk accounts for 97.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $47,502 and has fallen 95.3% since, to $2,247 in 2025. Among internal medicine clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $492.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$65K
- Dexcom, Inc.$821
- Abbott$290
- Insulet Corporation$138
- Boehringer Ingelheim$127
- Lilly USA, LLC$121
- plus $360 from 7 others
Across 2 payments — averaging $15,472 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$31K
What the payments were for
- Consulting fees$2,1303%
- Speaking & faculty fees$55,29683%
- Travel & lodging$6,33510%
- Food & beverage$2,5564%
- Education$1960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 81 | $64,656 |
| Dexcom, Inc. | 23 | $821 |
| Abbott | 4 | $290 |
| Insulet Corporation | 3 | $138 |
| Boehringer Ingelheim | 8 | $127 |
| Lilly USA, LLC | 8 | $121 |
| Zealand Pharma US, Inc. | 1 | $89 |
| Sanofi-aventis U.S. LLC | 2 | $84 |
| Medline Industries LP | 1 | $71 |
| Janssen Scientific Affairs, LLC | 1 | $64 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $16 |
| Companion Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$22,584
- Tresiba$18,804
- RYBELSUS$12,446
- Xultophy 100/3.6$9,106
- DEXCOM G6 TRANSMITTER$115
How this compares
$66,513 in reported general payments places this provider in the 95th percentile of 244 internal medicine providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 88 | $102,769 |
| JardianceEmpagliflozin | 70 | $70,619 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 58 | $61,795 |
| OzempicSemaglutide | 23 | $30,377 |
| TrulicityDulaglutide | 13 | $27,436 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $18,517 |
| FarxigaDapagliflozin Propanediol | 18 | $15,716 |
| Repatha SureclickEvolocumab | 16 | $13,603 |
| Saxagliptin Hcl | 12 | $3,419 |
| HumalogInsulin Lispro | 12 | $2,491 |
| Carbamazepine | 14 | $1,062 |
| Metformin Hcl ErMetformin Hcl | 54 | $563 |
| Losartan Potassium | 56 | $446 |
| SynthroidLevothyroxine Sodium | 15 | $387 |
| Omeprazole | 36 | $332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $121 | $132,695113 claims |
| Boehringer IngelheimJardiance | $127 | $70,61970 claims |
| Novo NordiskOzempic | $64,656 | $30,37723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 244 internal medicine providers in Montana.
Other internal medicine in Missoula
- Kimberly DamrowMissoula$2K
- David ObriantMissoula$2K
- Sean SnyderMissoula$1K
- J CaldwellMissoula$326
- Clare BrownleeMissoula$240
- Morgan McCarthyMissoula$228
- Frederick TaiMissoula$200
- Clancy ConeMissoula$192
- Joseph PeilaBillings$148K
- Kari KaleBillings$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.